Age-specific unweighted mortality rates (per 1000 person-years), by calendar-period, among individuals on ART in the NA-ACCORD, 2000–2007.

<p>Note: PY, person-years; ART, combination antiretroviral therapy.</p

Life expectancy estimates (LEE) and standard errors (SE) at age 20 years using weighted and unweighted mortality rates, 2000 to 2007.

<p>Note: LEE, <i>life expectancy estimate (years)</i>; SE, <i>standard error</i>; ART, <i>combination antiretroviral therapy</i>.</p><p>In effort to reduce bias from informative censoring, we used weighted regression methods to estimate mortality rates, using an indicator variable that was created to identify participants who were lost to follow-up. Further details are available in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0081355#pone.0081355.s002" target="_blank">Appendix S2</a>.</p

Life expectancy estimates (LEE) and standard errors (SE) at age 20 years using unweighted mortality rates, by calendar period, 2000 to 2007.

<p>Note: LEE, <i>life expectancy estimate (years)</i>; SE, <i>standard error</i>; ART, <i>combination antiretroviral therapy</i>.</p

Mid-point life expectancy estimates at age 20 years in three calendar periods, overall and by sociodemographic characteristics, 2000–2007.

<p>Panel A: Life expectancy at age 20 years, overall. Panel B: Life expectancy at age 20 years, by sex. Panel C: Life expectancy at age 20 years, by transmission group. Panel D: Life expectancy at age 20 years, by race. Panel E: Life expectancy at age 20 years, by CD4 cell count (cells/mm³) at ART initiation.</p

Population size, deaths, and unweighted mortality rate, overall and by select categories, 2000 to 2007.

<p>Per 1,000 person-years.</p><p>CI: Confidence Interval.</p><p>Note: ART, <i>combination antiretroviral therapy</i>.</p